Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Published 19/12/2023, 18:34
Updated 19/12/2023, 19:40
© Reuters.  Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.

Compugen shares jumped 204.1% to $2.22 on Tuesday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Intelligent Bio Solutions Inc. (NASDAQ: INBS) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.
  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares surged 64% to $1.6601. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.
  • Jin Medical International Ltd.(NASDAQ: ZJYL) climbed 49.2% to $151.96 after jumping around 264% on Monday.
  • ProSomnus, Inc. (NASDAQ: OSA) gained 27.6% to $0.8017. ProSomnus announced data published by Cureus Journal of Medical Science showed successful treatment of obstructive sleep apnea with prosomnus precision oral appliance devices.
  • Infobird Co., Ltd (NASDAQ: IFBD) shares gained 27.4% to $1.7266 after the company inked a new business cooperation in software development of information technology system.
  • MIND Technology, Inc. (NASDAQ: MIND) rose 23.1% to $5.86.
  • Yoshiharu Global Co. (NASDAQ: YOSH) rose 21.1% to $6.20.
  • Optex Systems Holdings, Inc (NASDAQ: OPXS) gained 18.2% to $4.86.
  • Sunnova Energy International Inc. (NASDAQ: NOVA) jumped 16.3% to $15.32. Piper Sandler upgraded Sunnova Energy Intl from Neutral to Overweight and raised the price target from $13 to $26.
  • Cipher Mining Inc. (NASDAQ: CIFR) rose 16% to $3.6450.
  • LogicMark, Inc. (NASDAQ: LGMK) gained 15.7% to $1.0650.
  • Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) climbed 13.8% to $2.0825. HC Wainwright & Co. reiterated Checkpoint Therapeutics with a Buy and maintained a $34 price target.
  • Affirm Holdings, Inc. (NASDAQ: AFRM) gained 13.6% to $49.64 after the company announced it has expanded its services to self-checkout at Walmart stores.
  • PureCycle Technologies, Inc. (NASDAQ: PCT) gained 13.2% to $3.17. Roth MKM downgraded PureCycle Technologies from Buy to Neutral and lowered the price target from $6 to $3.
  • bioAffinity Technologies, Inc. (NASDAQ: BIAF) rose 12.2% to $1.57.
  • Sunrun Inc. (NASDAQ: RUN) gained 9.4% to $19.72 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $15 to $31.
  • Chewy, Inc. (NYSE: CHWY) rose 7.1% to $23.22. Jefferies initiated coverage on Chewy with a Buy rating and announced a price target of $27.
  • Marathon Digital Holdings, Inc. (NASDAQ: MARA) gained 6% to $21.09. Marathon Digital entered into a definitive agreement Tuesday to acquire two Bitcoin mining sites for $178.6 million.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) fell 49.3% to $0.3501 after the company reported pricing of $1.5 million registered direct offering.
  • Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell 45.6% to $1.17 after the company priced its $5 million public offering.
  • CureVac N.V. (NASDAQ: CVAC) declined 35.7% to $3.7384. CureVac announced decision of German Federal Patent Court in broad patent litigation with BioNTech SE.
  • ETAO International Co., Ltd. (NASDAQ: ETAO) fell 34.7% to $0.3001. ETAO International received a staff determination letter, on Dec. 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC.
  • Shengfeng Development Limited (NASDAQ: SFWL) declined 32.4% to $3.24.
  • Banzai International, Inc. (NASDAQ: BNZI) fell 26.5% to $4.5006.
  • Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) declined 20.2% to $2.4150 after the company disclosed the pricing of a public offering.
  • AEye, Inc. (NASDAQ: LIDR) fell 18.8% to $0.0820. Representatives of Continental informed AEye that Continental intends to discontinue the parties' joint lidar development program, including any further development of the HRL131 lidar product line.
  • Invivyd, Inc. (NASDAQ: IVVD) fell 16.4% to $3.00. Morgan Stanley upgraded Invivyd from Underweight to Equal-Weight and raised the price target from $1 to $4.
  • Biomerica, Inc. (NASDAQ: BMRA) shares fell 16.3% to $1.3798. Biomerica shares gained around 67% on Monday after the company received FDA 510(k) clearance for its Hp Detect ELISA test product.
  • BIO-key International, Inc. (NASDAQ: BKYI) declined 16.3% to $0.1461. Following stockholder approval, BIO-Key announced a 1-for-18 reverse stock split to regain compliance with Nasdaq minimum bid price requirement.
  • bluebird bio, Inc. (NASDAQ: BLUE) shares fell 14.2% to $2.6180 after the company announced a proposed public offering of $150 million of common stock.
  • ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) fell 14% to $0.92 after surging 38% on Monday.
  • Diversified Energy Co PLC (NYSE: DEC) declined 12% to $15.77.
  • Alaunos Therapeutics, Inc (NASDAQ: TCRT) fell 10.6% to $0.0513 after jumping 26% on Monday.
  • uniQure N.V. (NASDAQ: QURE) fell 9.8% to $7.20 after announcing updated interim data on Phase I/II clinical trials of AMT-130 gene therapy for the treatment of Huntington's disease.
  • iCoreConnect Inc. (NASDAQ: ICCT) fell 8.3% to $2.1193 after jumping over 35% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: How To Earn $500 A Month From General Mills Stock Ahead of Quarterly Earnings Report

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.